批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
| 审批日期 | 提交号 | 审批结论 | 提交分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 1973/03/14 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
>>>补充申请<<<
| 审批日期 | 提交号 | 审批结论 | 补充类别或审批类型 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2023/12/15 |
SUPPL-45(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2021/09/13 |
SUPPL-43(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2021/06/02 |
SUPPL-41(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2019/10/07 |
SUPPL-38(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2018/02/01 |
SUPPL-32(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2016/12/16 |
SUPPL-29(补充) |
Approval |
Labeling-Package Insert,Labeling-Medication Guide,Labeling-Package Insert |
STANDARD
|
|
|
| 2014/09/22 |
SUPPL-27(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2014/06/02 |
SUPPL-26(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2008/02/04 |
SUPPL-21(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2005/08/03 |
SUPPL-19(补充) |
Approval |
Manufacturing (CMC)-Control |
STANDARD
|
|
|
| 2005/08/03 |
SUPPL-18(补充) |
Approval |
Manufacturing (CMC)-Control |
STANDARD
|
|
|
| 2005/05/26 |
SUPPL-16(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2005/05/26 |
SUPPL-15(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2002/03/27 |
SUPPL-14(补充) |
Approval |
Manufacturing (CMC)-Control |
STANDARD
|
|
|
| 2000/04/03 |
SUPPL-13(补充) |
Approval |
Manufacturing (CMC)-Control |
STANDARD
|
|
|
| 1993/04/20 |
SUPPL-12(补充) |
Approval |
Labeling |
|
|
|
| 1982/09/07 |
SUPPL-10(补充) |
Approval |
Manufacturing (CMC)-Formulation |
STANDARD
|
|
|
| 1981/11/25 |
SUPPL-9(补充) |
Approval |
Manufacturing (CMC)-Formulation |
STANDARD
|
|
|
| 1980/02/06 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 1980/02/06 |
SUPPL-7(补充) |
Approval |
Labeling |
|
|
|
| 1977/02/11 |
SUPPL-2(补充) |
Approval |
Labeling |
|
|
|
| 1976/08/06 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC)-Formulation |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
| 关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
| 无 |
与本品治疗等效的药品
>>>活性成分:METHADONE HYDROCHLORIDE; 剂型/给药途径:CONCENTRATE;ORAL; 规格:10MG/ML; 治疗等效代码:AA<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 017116 |
002 |
NDA |
METHADOSE |
METHADONE HYDROCHLORIDE |
CONCENTRATE;ORAL |
10MG/ML |
Prescription |
Yes |
Yes |
AA |
Approved Prior to Jan 1, 1982
|
SPECGX LLC |
| 089897 |
001 |
ANDA |
METHADONE HYDROCHLORIDE INTENSOL |
METHADONE HYDROCHLORIDE |
CONCENTRATE;ORAL |
10MG/ML |
Prescription |
No |
No |
AA |
1988/09/06
|
HIKMA |
| 040088 |
001 |
ANDA |
METHADONE HYDROCHLORIDE |
METHADONE HYDROCHLORIDE |
CONCENTRATE;ORAL |
10MG/ML |
Prescription |
No |
No |
AA |
1994/11/30
|
VISTAPHARM LLC |
| 040180 |
001 |
ANDA |
METHADONE HYDROCHLORIDE |
METHADONE HYDROCHLORIDE |
CONCENTRATE;ORAL |
10MG/ML |
Prescription |
No |
No |
AA |
1998/04/30
|
HIKMA |
| 207368 |
001 |
ANDA |
METHADONE HYDROCHLORIDE |
METHADONE HYDROCHLORIDE |
CONCENTRATE;ORAL |
10MG/ML |
Prescription |
No |
No |
AA |
2019/08/22
|
SPECGX LLC |
| 212093 |
001 |
ANDA |
METHADONE HYDROCHLORIDE |
METHADONE HYDROCHLORIDE |
CONCENTRATE;ORAL |
10MG/ML |
Prescription |
No |
No |
AA |
2020/11/02
|
LANNETT CO INC |